NanoViricides, Inc. (NNVC)
1.44
-0.07
(-4.64%)
USD |
NYAM |
Oct 22, 15:16
NanoViricides Market Cap : 33.13M for Oct. 22, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 21, 2026 | 34.74M |
| October 20, 2026 | 34.05M |
| October 19, 2026 | 29.91M |
| October 16, 2026 | 31.75M |
| October 15, 2026 | 31.52M |
| October 14, 2026 | 30.14M |
| October 13, 2026 | 30.37M |
| October 12, 2026 | 29.45M |
| October 09, 2026 | 29.91M |
| October 08, 2026 | 30.14M |
| October 07, 2026 | 33.13M |
| October 06, 2026 | 32.21M |
| October 05, 2026 | 33.36M |
| October 02, 2026 | 29.45M |
| October 01, 2026 | 28.99M |
| September 30, 2026 | 29.91M |
| September 29, 2026 | 29.91M |
| September 28, 2026 | 34.51M |
| September 25, 2026 | 33.13M |
| September 24, 2026 | 33.13M |
| September 23, 2026 | 34.74M |
| September 22, 2026 | 33.12M |
| September 21, 2026 | 36.58M |
| September 18, 2026 | 30.74M |
| September 17, 2026 | 30.31M |
| Date | Value |
|---|---|
| September 16, 2026 | 25.98M |
| September 15, 2026 | 22.73M |
| September 14, 2026 | 22.73M |
| September 11, 2026 | 22.08M |
| September 10, 2026 | 22.08M |
| September 09, 2026 | 22.51M |
| September 08, 2026 | 23.38M |
| September 04, 2026 | 24.24M |
| September 03, 2026 | 24.89M |
| September 02, 2026 | 25.33M |
| September 01, 2026 | 26.19M |
| August 31, 2026 | 27.06M |
| August 28, 2026 | 26.84M |
| August 27, 2026 | 27.71M |
| August 26, 2026 | 27.71M |
| August 25, 2026 | 27.92M |
| August 24, 2026 | 27.49M |
| August 21, 2026 | 28.79M |
| August 20, 2026 | 28.36M |
| August 19, 2026 | 29.01M |
| August 18, 2026 | 29.22M |
| August 17, 2026 | 29.44M |
| August 14, 2026 | 29.87M |
| August 13, 2026 | 29.44M |
| August 12, 2026 | 29.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.499B |
| Alnylam Pharmaceuticals, Inc. | 30.38B |
| Anika Therapeutics, Inc. | 279.04M |
| Savara, Inc. | 926.35M |
| Vericel Corp. | 2.179B |
Market Cap Related Metrics
| Price to Book Value | 3.816 |
| Price | 1.44 |
| Earnings Yield | -28.34% |